Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery

NCT00338585 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

300

Enrollment

INDUSTRY

Sponsor class

Stopped Based upon preliminary safety and efficacy results from a similar study.

Conditions

Arterial Occlusive Diseases

Interventions

DRUG: alfimeprase

Sponsor

ARCA Biopharma, Inc.